[Mutational analysis of KRAS prior to targeted therapy in colorectal cancer. Quality control of molecular pathological methods in Sweden]

MeSH terms

• Antibodies, Monoclonal / therapeutic use
• Antineoplastic Agents / therapeutic use
• Colorectal Neoplasms / drug therapy
• Colorectal Neoplasms / genetics*
• DNA Mutational Analysis
• ErbB Receptors / drug effects
• ErbB Receptors / physiology
• Genes, ras / genetics*
• Genetic Testing / methods
• Genetic Testing / standards
• Humans
• Mutation / genetics
• Polymerase Chain Reaction
• Precision Medicine
• Proto-Oncogene Proteins / genetics*
• Proto-Oncogene Proteins p21(ras)
• Quality Assurance, Health Care
• Sequence Analysis, DNA
• ras Proteins / genetics*